- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Piramal Pharma Limited — Important, 02-06-2025: General Updates
02-06-2025 | 10:44 am
02-06-2025 | 10:44 am
Piramal Pharma’s Aurora, Canada facility passed the US FDA GMP inspection with zero observations and earned a No Action Indicated status. This confirms high compliance and quality standards, enhancing operational credibility and potentially speeding up future regulatory approvals.
No comments yet. Be the first to comment!